CD44 and breast carcinoma: CD44 was previously described as a putative tumorigenic marker in breast cancer[19], andtumorsphere-forming cells were frequently enriched by isolating theCD44high/CD24low cell population [16], [18], [20], [21], although the propertiesof the cell subgroup expressing CD44 and its specific role in tumor-initiationremain controversial.